For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes
āHis efforts were largely fragmented and faced resistance from both the industry and lawmakers,ā said Sergio Jose Gutierrez, a political strategist who has primarily worked with Democrats in the U.S. āThe lack of a cohesive strategy and the limited ability to implement significant changes made his approach less effective compared to what a Harris-Walz administration could offer.ā